Portfolio

Affron®️ is standardized to Lepticrosalides®️, a set of biomolecules responsible for the beneficial effects of affron®️. It has 6 human clinical studies already published, one of which was carried out on adolescents and is internationally patented. It provides robust dose-response evidence with a significant effect in 2 weeks. A recent study showed that affron®️, in combination with antidepressants, is associated with an increase in the effectiveness of the drugs and an improvement in the quality of life of patients, due to a decrease in adverse effects. Affron ®️ may help against depression, anxiety and sleep disorders, and is the biomolecule with the fastest absorption, in just 1 hour.

ADD-ON TO ANTIDEPRESSANTS

IMPROVE MOOD IN TEENAGERS

MENOPAUSAL WOMEN

SLEEP